Organon & Co (United States) is listed on the Nasdaq and has a market capitalization of $3.51 Billions, with shareholders equity totaling $903.00 Thousand.
The Company is listed on the [MARKET_NAME]
Over the past 12 months, Organon & Co reported $4.57 Billions in revenue, generating net income of $14.23 Millions.
Key financial metrics include a P/E ratio of 246.79, a price-to-book (P/B) ratio of 3,889.58, and a trailing twelve-month dividend yield of 0.60%.
The company trades under the ticker OGN.